Capsugel CEO Driesen Plots Post-Pfizer Course

Guido Driesen, president and CEO of Capsugel, says the oral dosage technology firm is having a record year after being divested by Pfizer. In an interview, he discusses the firm’s applications for OTC drugs and nutritionals, as well as Capsugel’s international expansion.

After 50 years, Capsugel is now operating independent of a pharma parent. Pfizer Inc. divested the world’s largest manufacturer of empty capsules for the pharmaceutical and dietary supplement industries to private equity firm in a $2.38 billion deal that closed Aug. 1 Also see "Freed From Pfizer, Capsugel May Find More Market Opportunities" - Pink Sheet, 11 April, 2011..

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America